Evonik Industries Valuation
Is EVK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EVK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EVK (€17.69) is trading below our estimate of fair value (€43.1)
Significantly Below Fair Value: EVK is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EVK?
Key metric: As EVK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is EVK's PE Ratio? | |
|---|---|
| PE Ratio | 35.9x |
| Earnings | €229.00m |
| Market Cap | €8.22b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.8x |
| Enterprise Value/EBITDA | 6.1x |
| PEG Ratio | 1.1x |
Price to Earnings Ratio vs Peers
How does EVK's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 22x | ||
SY1 Symrise | 36.9x | 12.6% | €14.5b |
WCH Wacker Chemie | 29.4x | 38.0% | €3.6b |
ACT AlzChem Group | 11.7x | 12.6% | €586.2m |
UZU Uzin Utz | 10.2x | 2.1% | €243.1m |
EVK Evonik Industries | 35.9x | 33.1% | €8.2b |
Price-To-Earnings vs Peers: EVK is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the peer average (22x).
Price to Earnings Ratio vs Industry
How does EVK's PE Ratio compare vs other companies in the European Chemicals Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: EVK is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the European Chemicals industry average (17.9x).
Price to Earnings Ratio vs Fair Ratio
What is EVK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 35.9x |
| Fair PE Ratio | 23.3x |
Price-To-Earnings vs Fair Ratio: EVK is expensive based on its Price-To-Earnings Ratio (35.9x) compared to the estimated Fair Price-To-Earnings Ratio (23.3x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €17.69 | €22.48 +27.1% | 12.1% | €26.00 | €16.60 | n/a | 16 |
| Nov ’25 | €20.21 | €22.96 +13.6% | 9.6% | €26.00 | €19.90 | n/a | 16 |
| Oct ’25 | €20.99 | €22.49 +7.2% | 9.8% | €26.00 | €19.00 | n/a | 16 |
| Sep ’25 | €19.99 | €22.46 +12.4% | 9.9% | €26.00 | €19.00 | n/a | 16 |
| Aug ’25 | €19.14 | €22.46 +17.4% | 9.8% | €26.00 | €19.00 | n/a | 16 |
| Jul ’25 | €18.90 | €21.79 +15.3% | 10.6% | €25.00 | €17.50 | n/a | 17 |
| Jun ’25 | €20.20 | €21.84 +8.1% | 10.7% | €25.00 | €17.50 | n/a | 18 |
| May ’25 | €19.49 | €20.70 +6.2% | 13.0% | €25.00 | €17.00 | n/a | 18 |
| Apr ’25 | €18.40 | €20.22 +9.9% | 14.3% | €25.00 | €17.00 | n/a | 18 |
| Mar ’25 | €17.25 | €20.28 +17.6% | 14.8% | €25.00 | €16.00 | n/a | 18 |
| Feb ’25 | €17.19 | €20.28 +18.0% | 14.8% | €25.00 | €16.00 | n/a | 18 |
| Jan ’25 | €18.50 | €20.49 +10.8% | 15.4% | €26.00 | €16.00 | n/a | 18 |
| Dec ’24 | €17.35 | €20.64 +18.9% | 15.4% | €26.00 | €16.00 | n/a | 17 |
| Nov ’24 | €17.43 | €20.28 +16.4% | 15.4% | €26.00 | €16.50 | €20.21 | 18 |
| Oct ’24 | €17.33 | €20.56 +18.6% | 15.5% | €26.00 | €16.50 | €20.99 | 18 |
| Sep ’24 | €17.90 | €20.32 +13.5% | 16.3% | €26.00 | €15.00 | €19.99 | 19 |
| Aug ’24 | €18.75 | €20.55 +9.6% | 15.3% | €26.00 | €15.00 | €19.14 | 19 |
| Jul ’24 | €17.39 | €21.82 +25.5% | 16.3% | €29.00 | €15.00 | €18.90 | 20 |
| Jun ’24 | €17.69 | €22.59 +27.7% | 16.1% | €29.00 | €15.00 | €20.20 | 20 |
| May ’24 | €19.80 | €23.28 +17.6% | 18.1% | €31.00 | €15.00 | €19.49 | 20 |
| Apr ’24 | €19.36 | €23.43 +21.0% | 18.2% | €31.00 | €15.00 | €18.40 | 20 |
| Mar ’24 | €20.15 | €23.44 +16.3% | 18.9% | €30.00 | €15.00 | €17.25 | 20 |
| Feb ’24 | €20.62 | €23.49 +13.9% | 18.1% | €30.00 | €15.00 | €17.19 | 20 |
| Jan ’24 | €17.91 | €24.04 +34.2% | 19.5% | €34.00 | €15.00 | €18.50 | 20 |
| Dec ’23 | €18.63 | €24.45 +31.3% | 18.7% | €34.00 | €16.50 | €17.35 | 20 |
| Nov ’23 | €18.49 | €24.92 +34.8% | 20.6% | €36.00 | €16.50 | €17.43 | 20 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.
Discover undervalued companies
Tokuyama
JP¥189.7b
Produces and sells various chemical products in Japan.
TBT
JP¥15.90
7D
-1.9%
1Y
12.0%
Central Asia Metals
UK£279.8m
Operates as a base metals producer.
9C3
UK£1.97
7D
3.1%
1Y
2.1%
Cabka
€64.2m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
7GW
€2.54
7D
0%
1Y
-63.2%